Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2020
Total Assets: $118.48B
Liabilities Breakdown FY2020
Total Liabilities: $80.60B
Asset Breakdown
Total Assets: $118.48B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $14.55B | 12.3% |
| Accounts Receivable | $7.22B | 6.1% |
| Inventory | $2.07B | 1.8% |
| Property, Plant & Equipment | $5.89B | 5.0% |
| Goodwill | $20.55B | 17.3% |
| Intangible Assets | $53.24B | 44.9% |
| Other Assets | $14.97B | 12.6% |
Liabilities Breakdown
Total Liabilities: $80.60B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.71B | 3.4% |
| Long-Term Debt | $48.34B | 60.0% |
| Other Liabilities | $29.55B | 36.7% |